Reporting owner · CIK 0001271081

Jenkins George M

SEC Form 4 history across 1 companies, 26 transactions and 2 filings.

DIRPALVELLA THERAPEUTICS, INC.
Open-market transaction mix0% buys0 buys · 26 sales
Latest filingOct 14, 2026, 11:14 PM

Available history · Sep 11, 2026 – Oct 14, 2026

Filings2Form 4 records
Buying$00 purchases
Selling$7.7M26 sales
Net value−$7.7MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Jenkins George M transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
PVLAPALVELLA THERAPEUTICS, INC.
Jenkins George MDIRS · sale10b5-1 detectedSEC filing ↗-$238kView disclosure →
PVLAPALVELLA THERAPEUTICS, INC.
Jenkins George MDIRS · sale10b5-1 detectedSEC filing ↗-$937kView disclosure →
PVLAPALVELLA THERAPEUTICS, INC.
Jenkins George MDIRS · sale10b5-1 detectedSEC filing ↗-$853kView disclosure →
PVLAPALVELLA THERAPEUTICS, INC.
Jenkins George MDIRS · sale10b5-1 detectedSEC filing ↗-$194kView disclosure →
PVLAPALVELLA THERAPEUTICS, INC.
Jenkins George MDIRS · sale10b5-1 detectedSEC filing ↗-$694kView disclosure →
PVLAPALVELLA THERAPEUTICS, INC.
Jenkins George MDIRS · sale10b5-1 detectedSEC filing ↗-$982kView disclosure →
Open a transaction for shares, transaction date, ownership and the original SEC filing.

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at PALVELLA THERAPEUTICS, INC. on Oct 14, 2026 valued at $63,910.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at PALVELLA THERAPEUTICS, INC. on Oct 14, 2026 valued at $63,910.

Review SEC filing

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202609$0.00$4,167,146.09-$4,167,146.09
Oct 2026017$0.00$3,579,476.19-$3,579,476.19

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$297.9K
Median P/S size$195.5K
Direct26
Indirect0
Oct 14, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Direct Ownershipfiling-context17Large Salesize1Repeat Sellerpattern1710b5-1 Detectedfiling-context17

Associated companies

Companies in the disclosed reporting history

PALVELLA THERAPEUTICS, INC.PVLA · 27 transactions · latest Oct 14, 2026, 11:14 PM

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

26 observations · Sep 11, 2026 – Oct 14, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 14, 2026132,616 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 11, 2026181,096Sep 16, 2026View transaction
Sep 11, 2026176,519Sep 16, 2026View transaction
Sep 11, 2026175,245Sep 16, 2026View transaction
Sep 14, 2026169,613Sep 16, 2026View transaction
Sep 14, 2026163,453Sep 16, 2026View transaction
Sep 14, 2026161,893Sep 16, 2026View transaction
Sep 15, 2026160,939Sep 16, 2026View transaction
Sep 15, 2026160,676Sep 16, 2026View transaction
Sep 15, 2026160,116Sep 16, 2026View transaction
Oct 12, 2026155,021Oct 14, 2026View transaction
Oct 12, 2026152,563Oct 14, 2026View transaction
Oct 12, 2026149,228Oct 14, 2026View transaction
Oct 12, 2026147,781Oct 14, 2026View transaction
Oct 12, 2026146,964Oct 14, 2026View transaction
Oct 13, 2026144,960Oct 14, 2026View transaction
Oct 13, 2026143,316Oct 14, 2026View transaction
Oct 13, 2026142,326Oct 14, 2026View transaction
Oct 13, 2026141,291Oct 14, 2026View transaction
Oct 13, 2026140,712Oct 14, 2026View transaction
Oct 13, 2026139,790Oct 14, 2026View transaction
Oct 14, 2026139,314Oct 14, 2026View transaction
Oct 14, 2026137,242Oct 14, 2026View transaction
Oct 14, 2026134,638Oct 14, 2026View transaction
Oct 14, 2026133,718Oct 14, 2026View transaction
Oct 14, 2026133,121Oct 14, 2026View transaction
Oct 14, 2026132,616Oct 14, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Jenkins George M Insider Activity FAQ

SEC Form 4 context

Who is Jenkins George M?

Jenkins George M is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001271081.

Which companies has Jenkins George M reported transactions for?

PALVELLA THERAPEUTICS, INC.

When was Jenkins George M's latest insider buy?

No open-market insider purchase is available for this period.

When was Jenkins George M's latest insider sale?

sale at PALVELLA THERAPEUTICS, INC. on Oct 14, 2026 valued at $63,910.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.